Editorial Board
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - August 5, 2017 Category: Cardiology Source Type: research
Title Page
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - August 5, 2017 Category: Cardiology Source Type: research
Information for Readers
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - August 5, 2017 Category: Cardiology Source Type: research
Table of Contents
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - August 5, 2017 Category: Cardiology Source Type: research
Editorial Board (p/u from previous issue)
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - July 30, 2017 Category: Cardiology Source Type: research
Title Page (p/u from previous issue w/updates)
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - July 30, 2017 Category: Cardiology Source Type: research
Information for Readers (p/u from previous issue)
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - July 30, 2017 Category: Cardiology Source Type: research
Table of Contents (p/u from previous issue w/updates)
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - July 30, 2017 Category: Cardiology Source Type: research
Editor ’s Message
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - July 30, 2017 Category: Cardiology Source Type: research
Guidelines for Authors
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - July 30, 2017 Category: Cardiology Source Type: research
Oral Antidiabetic Agents and Cardiovascular Outcomes
Cardiovascular disease is the leading cause of morbidity and mortality among patients with type 2 diabetes; however, a direct protective effect of tight glycemic control remains unproven. In fact, until 2008, when concerns related to rosiglitazone prompted regulatory agencies to mandate assessment of cardiovascular safety of new antidiabetic agents, little was known about how these medications affected cardiovascular outcomes. Since then, there has been a considerable increase in the number of cardiovascular trials, which employ a non-inferiority design and focus on high-risk populations, to establish safety in the shortes...
Source: Current Problems in Cardiology - July 28, 2017 Category: Cardiology Authors: Manan Pareek, Deepak L. Bhatt Source Type: research
Editorial Board
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - July 26, 2017 Category: Cardiology Source Type: research
Title Page
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - July 26, 2017 Category: Cardiology Source Type: research
Information for Readers
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - July 26, 2017 Category: Cardiology Source Type: research
Table of Contents
(Source: Current Problems in Cardiology)
Source: Current Problems in Cardiology - July 26, 2017 Category: Cardiology Source Type: research
